Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd, formerly FSD Pharma Inc., is a biotechnology company. It operates in two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of its two primary drug candidates, consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. Its Strategic Investments segment is focused on... see more

Bullboard (CSE:QNTM)

View:
Post by Bigmac4000on Jul 25, 2024 5:43pm

This paragraph hurts my head

Someone read this paragraph and tell me if I'm crazy. The grammer is atrocious. Seemingly as unlucky to jump into the beverage market....... Then says they will have a beverage later this year ...more  
Post by JAKPUG4LIFEon Jul 24, 2024 12:13am

Re: They approved the RS

Yep pretty close on the shares Shares Outstanding 5 46.06  Single digit share ownership coming up and maybe than will see ...more  
Comment by Bigmac4000on Jul 23, 2024 11:06pm

RE:Results of Voting…

Yep, remember how we were ridiculed for bringing up this massive share structure and the false sense of security they gave people by making people think a vote counts. I was banned from the ...more  
Comment by GrahamBon Jul 23, 2024 7:15pm

RE:Results of Voting…

  'The full  reference/link  didn't come out  https://equity.guru/2018/05/31/its-happening-again-fsd-pharma-huge-c-is-an-insider-loaded-overvalued-restrictive-mess ...more  
Post by GrahamBon Jul 23, 2024 7:14pm

Results of Voting…

Funny how this update implies, imo, that the shareholders approved this reverse split. if you remember equity gurus comments here in 2018-it was right on the mark: "FSD Pharma (HUGE.C)  ...more  
Comment by GrahamBon Jul 23, 2024 6:57pm

RE:They approved the RS

Hey Big Mac Good summary-I agree This is unbelievable.
Comment by Bigmac4000on Jul 23, 2024 2:44pm

RE:New “article” on HUGE FYI

This is another pathetic "friend of the family" type of contract. $30,000 ($1000 a day) to promote what? I've seen maybe two articles. This article gave FSD a couple of paragraphs at ...more  
Post by GrahamBon Jul 23, 2024 10:55am

New “article” on HUGE FYI

New "article" on HUGE. The disclosures listed below are an interesting use of resources as is the word "traffic"  24/7 Market News Publishes Report Covering Biotech ...more  
Comment by rad10on Jul 12, 2024 3:28pm

RE:RE:RE:New Press Release - FSD Pharma Files Amended and Restated Material Change Report

This name is right up your alley Towering.........  nothing appealing for me.  So many red flags. What is your obsession with all gender bathrooms.  Live and let live, no big deal.
Comment by Toweringmarson Jul 09, 2024 9:35am

RE:RE:New Press Release - FSD Pharma Files Amended and Restated Material Change Report

Raddyboi, do you work for Totaligent?  I heard you clean the all gender restrooms there? Good promotional work! Are you buying more here?  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities